Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Anti-Dengue Vaccine May Be Linked to Three Deaths in the Philippines, Task Force Reports

  • Post author:Sam
  • Post published:February 2, 2018
  • Post category:Drug Industry Daily

Philippine health officials investigating the anti-dengue vaccine Dengvaxia announced Friday that the drug may be linked to the deaths of three children. Source: Drug Industry Daily

Continue ReadingAnti-Dengue Vaccine May Be Linked to Three Deaths in the Philippines, Task Force Reports

New York AG Sues Insys Alleging Illegal Off-Label Promotion, Bribery to Boost Fentanyl Drug

  • Post author:Sam
  • Post published:February 2, 2018
  • Post category:Drug Industry Daily

New York’s attorney general is suing Insys for deceptive marketing of the spray form of one of its fentanyl products, a move the state says is part of a multi-pronged…

Continue ReadingNew York AG Sues Insys Alleging Illegal Off-Label Promotion, Bribery to Boost Fentanyl Drug

FDA Adds Black Box Warning to Intercept’s Liver Disease Medicine

  • Post author:Sam
  • Post published:February 2, 2018
  • Post category:Drug Industry Daily

The FDA issued a black box warning for Ocaliva (obeticholic acid), a liver disease medication that was incorrectly dosed as daily instead of weekly for patients with primary biliary cholangitis…

Continue ReadingFDA Adds Black Box Warning to Intercept’s Liver Disease Medicine

Study: Generic Substitution Could Have Saved Medicare $2.9 Billion

  • Post author:Sam
  • Post published:February 2, 2018
  • Post category:Drug Industry Daily

Medicare could have saved up to $3 billion over a five-year period if they used the same strategy employed by pharmacy benefit managers for privately-insured patients to favor generics, according…

Continue ReadingStudy: Generic Substitution Could Have Saved Medicare $2.9 Billion

Mysterious Biotech Unicorn Moderna Nabs Another $500M, Is Now Worth $7B

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

One can only hope that Moderna Therapeutics can live up to the hype, both scientifically and financially. Source: BioSpace

Continue ReadingMysterious Biotech Unicorn Moderna Nabs Another $500M, Is Now Worth $7B

Amgen to Build New $300M Facility After Tax Changes

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

Amgen is expected to add 220 jobs to the local economy and employ up to 300 full-time employees. Source: BioSpace

Continue ReadingAmgen to Build New $300M Facility After Tax Changes

Arcturus CEO Ousted, Effective Immediately

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

Shares of Arcturusare down more than 8 percent in morning trading after the company announced it abruptly terminated Joseph E. Payne as president and CEO. Source: BioSpace

Continue ReadingArcturus CEO Ousted, Effective Immediately

AbbVie Plans to Hire After Doubling Cambridge R&D Facility

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

With the additional space, AbbVie will hire 15 new employees. Source: BioSpace

Continue ReadingAbbVie Plans to Hire After Doubling Cambridge R&D Facility

3 Best Biotherapeutics Stocks to Buy Right Now

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

Sometimes the biggest are also the best. That's the case for biotherapeutics stocks. Source: BioSpace

Continue Reading3 Best Biotherapeutics Stocks to Buy Right Now

Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025

  • Post author:Sam
  • Post published:February 1, 2018
  • Post category:BioPharma

Alder intends to use the cash to fund the development and commercialization of eptinezumab. Source: BioSpace

Continue ReadingAlder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025
  • Go to the previous page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.